Accelerated atheroma in lupus—background

作者: M B Urowitz , D D Gladman

DOI: 10.1191/096120300678828271

关键词:

摘要: Observational cohort studies in SLE have led to the description of accelerated atherosclerosis as an important cause mortality and morbidity this disease. The clinical observation coronary artery disease occurring premenopausal females with gave rise concept bimodal pattern. This pattern was confirmed autopsy epidemiological studies. These identified hypercholesterolemia particularly its persistence first three years disease, hypertension, lupus itself risk factors for development these patients. It also became evident that corticosteroid therapy plays role elevation plasma lipids while antimalarials resulted a reduction cholesterol, LDL, VLDL, especially steroid-induced hyperlipidemia. Studies outcomes atherosclerotic (angina, myocardial infarction) shown prevalence 6-12% number cohorts. However, more sensitive investigations including perfusion imaging carotid ultrasound demonstrated 40% patients studied. Further process, immunological factors, may clearly define pathogenesis SLE, help elucidate mechanisms general population.

参考文章(38)
Bruce In, Gladman Dd, Hallett Dc, Urowitz Mb, Natural history of hypercholesterolemia in systemic lupus erythematosus. The Journal of Rheumatology. ,vol. 26, pp. 2137- 2143 ,(1999)
M. B. Urowitz, Mahmoud Abu-Shakra, J. Gough, D. D. Gladman, Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. The Journal of Rheumatology. ,vol. 22, pp. 1259- 1264 ,(1995)
EF Borba, RD Santos, E Bonfa, CG Vinagre, FJ Pileggi, W Cossermelli, Raul Cavalcante Maranhão, None, Lipoprotein(a) levels in systemic lupus erythematosus. The Journal of Rheumatology. ,vol. 21, pp. 220- 223 ,(1994)
Matthew H. Liang, Steven A. Socher, Martin G. Larson, Peter H. Schur, Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus Arthritis & Rheumatism. ,vol. 32, pp. 1107- 1118 ,(1989) , 10.1002/ANR.1780320909
Norman T. Ilowite, Paul Samuel, Ellen Ginzler, Marc S. Jacobson, Dyslipoproteinemia in pediatric systemic lupus erythematosus Arthritis & Rheumatism. ,vol. 31, pp. 859- 863 ,(1988) , 10.1002/ART.1780310706
Murray B. Urowitz, Arthur A.M. Bookman, Barry E. Koehler, Duncan A. Gordon, Hugh A. Smythe, Metro A. Ogryzlo, The bimodal mortality pattern of systemic lupus erythematosus The American Journal of Medicine. ,vol. 60, pp. 221- 225 ,(1976) , 10.1016/0002-9343(76)90431-9
J G Hanly, M B Urowitz, Tendon rupture in systemic lupus erythematosus. Annals of the Rheumatic Diseases. ,vol. 45, pp. 349- 349 ,(1986) , 10.1136/ARD.45.4.349-A
Susan Manzi, Faith Selzer, Kim Sutton-Tyrrell, Shirley G. Fitzgerald, Joan E. Rairie, Russell P. Tracy, Lewis H. Kuller, Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus Arthritis & Rheumatism. ,vol. 42, pp. 51- 60 ,(1999) , 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D
Daniel J. Wallace, Allan L. Metzger, Vera J. Stecher, Barry A. Turnbull, Philip A. Kern, Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: Reversal of deleterious effects of steroids on lipids The American Journal of Medicine. ,vol. 89, pp. 322- 326 ,(1990) , 10.1016/0002-9343(90)90345-E
D D Gladman, Murray B Urowitz, The SLICC/ACR damage index: progress report and experience in the field. Lupus. ,vol. 8, pp. 632- 637 ,(1999) , 10.1191/096120399680411335